GRCE Key Financial Ratios - Grace Therapeutics, Inc.

Complete source-backed ratio history.

Historical Key Financial Ratios

Date	Current ratio	Debt/equity	ROA	ROE
2026-06-30	11.47	—	-40.38%	-41.94%
2026-03-31	8.1	—	-11.69%	-12.20%
2025-12-31	14.96	—	-8.73%	-9.21%
2025-09-30	13.89	—	-11.74%	-12.45%
2025-06-30	8.87	—	-14.77%	-16.23%
2025-03-31	11.77	—	-13.29%	-14.36%
2024-12-31	6.06	—	-21.84%	-25.64%
2024-09-30	6.01	—	-17.76%	-20.68%
2024-06-30	7.86	—	-16.42%	-19.28%
2024-03-31	14.26	—	-17.53%	-20.82%
2023-12-31	15.19	—	-50.89%	-59.95%
2023-09-30	20.68	—	-51.49%	-60.34%
2023-06-30	12.01	—	-57.41%	-65.50%
2023-03-31	8.59	—	-53.62%	-62.44%
2022-12-31	9.74	—	-14.77%	-17.83%
2022-09-30	9.86	—	-14.17%	-17.11%
2022-06-30	11.13	—	-8.98%	-10.75%
2022-03-31	13.89	—	-7.63%	-9.07%
2021-12-31	16.91	—	-10.12%	-10.41%
2021-09-30	12.19	—	-9.18%	-9.63%
2021-06-30	25.75	—	-29.99%	-33.92%
2021-03-31	39.5	—	-31.51%	-35.35%
2020-12-31	13.43	—	8.52%	10.04%
2020-09-30	3.66	—	-45.69%	-71.23%
2020-06-30	2.34	—	-105.91%	-193.29%
2020-03-31	2.5	—	-111.64%	-196.34%
2019-03-31	2.05	—	—	—

Date	Current ratio	Debt/equity	ROA	ROE
2026-03-31	8.1	—	-11.69%	-12.20%
2025-03-31	11.77	—	-13.29%	-14.36%
2024-03-31	14.26	—	-17.53%	-20.82%
2023-03-31	8.59	—	-53.62%	-62.44%
2022-03-31	13.89	—	-7.63%	-9.07%
2021-03-31	39.5	—	-31.51%	-35.35%
2020-03-31	2.5	—	-111.64%	-196.34%
2019-03-31	2.05	—	-106.69%	-356.41%